Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Erlib 150mg Tablet
Manufacturer/Marketed By : NEON LABORATORIES LTD
$44.89 $26.94
Erlib 150mg Tablet contains an active substance Erlotinib. It is an anticancer medicine that belongs to the class tyrosine kinase receptor inhibitor. It is used in the treatment of non-small...
ERLOTINIB
Active Pharmaceutical Ingredient
Erlib 150mg Tablet
$44.89
$26.94
Erlib 150mg Tablet contains an active substance Erlotinib. It is an anticancer medicine that belongs to the class tyrosine kinase receptor inhibitor. It is used in the treatment of non-small cell lung cancer (NSCLC), an advanced and spreading type of lung cancer. When used in combination with gemcitabine, a chemotherapeutic medicine, it is also used to treat pancreatic cancer. It works by blocking the protein that increases the growth of the cancer, known as epidermal growth factor receptors (EGFR). If a test has shown that your cancer has certain changes in a gene called EGFR (epidermal growth factor receptor), the cancer can respond to the treatment with this medicine. Inform your doctor before starting treatment if you are using any stomach acid-lowering medicine, as it may prevent Erlib 150mg Tablet from working. Inform the physician if the patient has any kidney or lung-related problems. Make sure to inform your physician of all the medicines you are taking before you start the treatment with this medication. Report any symptoms of difficulty breathing together with a cough or fever, chest pain, fever, weakness, or seizures.
Active Pharmaceutical Ingredient
Uses
• Non-small cell lung cancer (NSCLC).
Benefits
Erlib 150mg Tablet works by inhibiting the epidermal growth factor receptor (EGFR), a protein responsible for cancer growth.
Side Effects
Like all medications, Erlib 150mg Tablet can cause side effects, although not everyone who takes it will experience them.
Most Common Side Effects
• Chest pain or discomfort
• Dehydration
• Slurred speech
• Seizures
• Black or bloody stools
• Inability to speak
• Constipation
• Blurred or change in vision
• Stomach pain or discomfort
• Unusual hair loss
• The skin may develop darker patches
• Depression
Common Side Effects
• Diarrhea (severe)
• Tingling, pain, numbness and burning sensation in the hands, arms, feet or legs
• Hoarseness or cough
• Lower back or side pain
• Pain or difficulty in urination
• Rash (severe)
• Loss of appetite and may lose weight
• Difficulty in breathing
• Eye problems
• Numbness or weakness in arms and legs
How To Use
Erlib 150mg Tablet should be taken orally as directed by your physician or pharmacist. It should be taken on an empty stomach at least 1 hour before food or 2 hours after food. Pregnant women should avoid this medicine as it may affect the growth of the child.
Safety Advice
• Breast Feeding: Don’t breastfeed while taking Erlib 150mg Tablet and for 2 weeks after your last dose because the drug may come through into your breast milk.
• Alcohol: It is not known whether it is safe to use Erlib 150mg Tablet while consuming alcohol. Consult the doctor before taking this medication.
• Liver: You need to tell your doctor if you have any liver disorders before taking Erlib 150mg Tablet. Your doctor may decide to adjust the dose or delay treating you depending on your liver function.
• Lungs: Erlib 150mg Tablet can be effective in treating NSCLC. Before starting treatment, talk to your doctor if you have any lung conditions.
• Driving: Erlib 150mg Tablet is not likely to affect driving and the use of any tools or machines.
• Pregnancy: Erlib 150mg Tablet is not safe for use during pregnancy because it can harm the developing baby.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.